Check out the @accintouch.bsky.social #ACC26 hands on learning #vaECMO #mcs this morning with me and my #CCC colleagues. Some fun, challenging cases to troubleshoot! #ACCcriticalcare #criticalcarecardiology #medsky #cccsky #cardiosky #cardiology

Excited for #ACC26 in #NewOrleans! Lots of #ACCcriticalcare activity to participate in, especially the #criticalcarecardiology simulation sessions on #mcs #vaECMO #shock @accintouch.bsky.social #cccsky #medsky #cardiosky

JAMA Research Summary: Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock. The study analyzes VA-ECMO weaning with levosimendan vs. placebo, finding no significant difference in primary outcomes.

📊 Research Summary: Early treatment with levosimendan was not associated with improved timing of ECMO weaning, lower mortality, or shorter ICU stay for adults with severe cardiogenic shock supported by #VAECMO.

ja.ma/49N3vny

Research summary: Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock. The study analyzes VA-ECMO weaning with levosimendan vs. placebo, finding no significant difference in outcomes.

📊 Research Summary: Early treatment with levosimendan was not associated with improved timing of ECMO weaning, lower mortality, or shorter ICU stay for adults with severe cardiogenic shock supported by #VAECMO.

ja.ma/4reZNtA

Getting in the Flow” discussing #vaECMO cannulation strategies and configurations with Dr. Bartos @umn-ccces.bsky.social @jameshorowitzmd.bsky.social @andrewhigginsmd.bsky.social
@bkatli.bsky.social #umnccces25 #cardiosky #cccsky